The Opportunity
Illumion Limited (“the Company” or “Illumion”) is revolutionising battery material R&D, making breakthroughs 10x faster and 100x cheaper.
- Developing new types of chemistries to improve the performance and reduce the cost of batteries is critical to decarbonising the global economy.
- The limiting factor in battery materials research is the use of instruments that are large, complex and expensive or cheap but offer limited functionality.
- The IllumionONE is a compact, desktop-sized device that revolutionises battery material research to unlock faster charging, higher energy densities and longer lifespans.
- £284k in orders have been received from early-adopter academic customers.
- The team bring decades of battery R&D experience from Cambridge, Oxford and Harvard.
- Backed by UK venture investors Foresight, Cambridge Enterprise Ventures (the University’s venture arm) and Refeyn, an Oxford-based life sciences microscopy pioneer.
- £2.5m is being raised to convert a £3.6m qualified sales pipeline and develop a second product for industry customers.
The Fundraise
- £2.5m (£3.45m Growthdeck pre-money valuation).
- £2.1m already invested from VCs.
- £400,000 opportunity for Growthdeck Investors (6% stake).
- Exit targeted from 2029 at £65m valuation (5x sales).
- EIS-qualifying.
Please join the network or log in to view full details and to access the Investment full details.
Investment details
Fundraise target£400,000
Fundraise maximum-
Minimum investment£5,000
Equity stake6%
Exit Money MultipleLog in to view
Exit IRRLog in to view
Company details
Name:Illumion Limited
Website:www.illumion.io
Address:
3rd Floor 1 Ashley Road
Altrincham
WA14 2DT
Incorporated: 23/06/22
Social sites:
Please note
We want our investors to be fully aware of the downsides of investing as well as the potential benefits. It's therefore important to realise that investing always carries risks, including the loss of capital, illiquidity (the inability to sell assets quickly or without substantial loss in value), lack of dividends and share dilution. Alternative investments should still be made as part of a diversified portfolio. Read our full Risk Warning